Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 232 articles:
HTML format
Text format



Single Articles


    April 2019
  1. SEGAR MW, Patel KV, Berry JD, Grodin JL, et al
    Generalizability and Implications of the H2FPEF Score in a Cohort of Patients With Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;139:1851-1853.
    PubMed     Text format    


  2. MORROW DA, Velazquez EJ, DeVore AD, Desai AS, et al
    Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.039331.
    PubMed     Text format    


  3. PATORNO E, Pawar A, Franklin JM, Najafzadeh M, et al
    Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care: A First Analysis from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.039177.
    PubMed     Text format     Abstract available


    March 2019
  4. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
    Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
    PubMed     Text format     Abstract available


  5. BOTS SH, den Ruijter HM
    Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
    Circulation. 2019;139:1469-1471.
    PubMed     Text format    


  6. KATO ET, Silverman MG, Mosenzon O, Zelniker TA, et al
    Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040130.
    PubMed     Text format     Abstract available


  7. VERMA S, McMurray JJV
    The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040514.
    PubMed     Text format     Abstract available


  8. FIGTREE GA, Radholm K, Barrett TD, Perkovic V, et al
    Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057.
    PubMed     Text format     Abstract available


  9. KUMAR AA, Kelly DP, Chirinos JA
    Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;139:1435-1450.
    PubMed     Text format     Abstract available


  10. SAVARESE G, Sattar N, Januzzi J, Verma S, et al
    Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.
    Circulation. 2019;139:1458-1460.
    PubMed     Text format    


    February 2019
  11. COLLINS SP, Pang PS
    ACUTE Heart Failure Risk Stratification.
    Circulation. 2019;139:1157-1161.
    PubMed     Text format    


  12. HSICH EM
    Sex Differences in Advanced Heart Failure Therapies.
    Circulation. 2019;139:1080-1093.
    PubMed     Text format     Abstract available


  13. CHARLES-EDWARDS G, Amaral N, Sleigh A, Ayis S, et al
    Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients with Chronic Heart Failure and Iron Deficiency: The FERRIC-HF II Randomized Mechanistic Trial.
    Circulation. 2019 Feb 19. doi: 10.1161/CIRCULATIONAHA.118.038516.
    PubMed     Text format     Abstract available


  14. DEL BUONO MG, Carbone S, Abbate A
    Letter by Del Buono et al Regarding Article, "A Simple, Evidence-Based Approach To Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2019;139:990-991.
    PubMed     Text format    


  15. COBOS GIL MA
    Letter by Cobos Gil Regarding Article, "A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2019;139:989.
    PubMed     Text format    


  16. REDDY YNV, Borlaug BA
    Response by Reddy and Borlaug to Letters Regarding Article, "A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2019;139:992-993.
    PubMed     Text format    


  17. MORDI IR, Pearson ER, Palmer CNA, Doney ASF, et al
    Differential Association of Genetic Risk of Coronary Artery Disease With Development of Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Circulation. 2019;139:986-988.
    PubMed     Text format    


  18. LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
    A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
    Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
    PubMed     Text format     Abstract available


    January 2019
  19. CHEN Y, Nilsson J, Liang C
    Letter by Chen et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
    Circulation. 2019;139:716-717.
    PubMed     Text format    


  20. MEIJERS WC, de Boer RA
    Response by Meijers and de Boer to Letters Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
    Circulation. 2019;139:720-721.
    PubMed     Text format    


  21. DEVORE AD, Bhatt AS
    Influenza Vaccination in Patients With Heart Failure.
    Circulation. 2019;139:587-589.
    PubMed     Text format    


  22. ZHANG J, Lan HY, Wan S
    Letter by Zhang et al Regarding Article, "Heart Failure Stimulates Tumor Growth by Circulating Factors".
    Circulation. 2019;139:718-719.
    PubMed     Text format    


  23. FIGTREE GA, Radholm K, Neal B
    Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:418-419.
    PubMed     Text format    


  24. KOH KK
    Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:416-417.
    PubMed     Text format    


  25. ZANNAD F, Rossignol P
    Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure.
    Circulation. 2019;139:362-365.
    PubMed     Text format    


  26. ZHOU L, Li Z, Wang DW
    Response by Zhou et al to Letter Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure".
    Circulation. 2019;139:301-302.
    PubMed     Text format    


  27. GREENE SJ, Butler J
    Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.
    Circulation. 2019;139:152-154.
    PubMed     Text format    


  28. FRANGOGIANNIS NG
    Protean Functions and Phenotypic Plasticity of Regulatory T Cells in Chronic Ischemic Heart Failure.
    Circulation. 2019;139:222-225.
    PubMed     Text format    


  29. MORIS D, Karachaliou GS, Karaolanis G
    Letter by Moris et al Regarding Article, "Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure".
    Circulation. 2019;139:299-300.
    PubMed     Text format    


    December 2018
  30. ANAND I, Gupta P
    Response by Anand and Gupta to Letter Regarding Article, "Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies".
    Circulation. 2018;138:2976-2977.
    PubMed     Text format    


  31. DE LAS NIEVES LOPEZ MA
    Letter by de las Nieves Lopez Regarding Article, "Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies".
    Circulation. 2018;138:2974-2975.
    PubMed     Text format    


  32. TROMP J, MacDonald MR, Tay WT, Teng TK, et al
    Heart Failure With Preserved Ejection Fraction in the Young.
    Circulation. 2018;138:2763-2773.
    PubMed     Text format     Abstract available


  33. AMBROSY AP, Parzynski CS, Friedman DJ, Fudim M, et al
    Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Circulation. 2018;138:2787-2797.
    PubMed     Text format     Abstract available


  34. JERNBERG T, Lindahl B, Alfredsson J, Berglund E, et al
    Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
    Circulation. 2018;138:2754-2762.
    PubMed     Text format     Abstract available


  35. MODIN D, Jorgensen ME, Gislason G, Jensen JS, et al
    Influenza Vaccine in Heart Failure: Cumulative Number of Vaccinations, Frequency, Timing, and Survival: A Danish Nationwide Cohort Study.
    Circulation. 2018 Dec 10. doi: 10.1161/CIRCULATIONAHA.118.036788.
    PubMed     Text format     Abstract available


  36. FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
    Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
    Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
    PubMed     Text format     Abstract available


    November 2018
  37. LEE DS, Lee JS, Schull MJ, Borgundvaag B, et al
    Prospective Validation of the Emergency Heart Failure Mortality Risk Grad for Acute Heart Failure: The Acute Congestive Heart Failure Urgent Care Evaluation (ACUTE) Study.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.035509.
    PubMed     Text format     Abstract available


  38. SHAH R, Latham SB
    Letter by Shah and Latham Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With the Guidelines-Heart Failure".
    Circulation. 2018;138:2303-2304.
    PubMed     Text format    


  39. REISMAN L
    Letter by Reisman Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
    Circulation. 2018;138:2301-2302.
    PubMed     Text format    


  40. MAHLA RS
    Letter by Mahla Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
    Circulation. 2018;138:2305.
    PubMed     Text format    


  41. KUMBHANI DJ, Fonarow GC, Heidenreich PA, Schulte PJ, et al
    Response by Kumbhani et al to Letters Regarding Article, "Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure".
    Circulation. 2018;138:2306-2307.
    PubMed     Text format    


  42. EVERETT BM, Cornel J, Lainscak M, Anker SD, et al
    Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038010.
    PubMed     Text format     Abstract available


  43. MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
    Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
    PubMed     Text format     Abstract available


  44. ARAGAM KG, Chaffin M, Levinson RT, McDermott G, et al
    Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035774.
    PubMed     Text format     Abstract available


    October 2018
  45. MATSUMOTO J, Takada S, Kinugawa S, Furihata T, et al
    Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
    Circulation. 2018;138:2064-2066.
    PubMed     Text format    


  46. LEROY J, Fischmeister R
    Inhibit a Phosphodiesterase to Treat Heart Failure?
    Circulation. 2018;138:2003-2006.
    PubMed     Text format    


  47. KOK W, Stienen S
    Response by Kok and Stienen to Letter Regarding Article, "NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Adm
    Circulation. 2018;138:1910-1911.
    PubMed     Text format    


  48. MADIAS JE
    Letter by Madias Regarding Article, "NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Deco
    Circulation. 2018;138:1908-1909.
    PubMed     Text format    


  49. MONTERO D
    Letter by Montero Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
    Circulation. 2018;138:1757-1758.
    PubMed     Text format    


  50. CALVERLEY TA, Bailey DM
    Letter by Calverley and Bailey Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
    Circulation. 2018;138:1755-1756.
    PubMed     Text format    


  51. HOWDEN EJ, Levine BD
    Response by Howden and Levine to Letters Regarding Article, "Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications for Heart Failure Prevention".
    Circulation. 2018;138:1759-1760.
    PubMed     Text format    


  52. ALOIA E
    Letter by Aloia Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality".
    Circulation. 2018;138:1612.
    PubMed     Text format    


  53. NUNEZ J, Nunez E, Sanchis J, Bayes-Genis A, et al
    Response by Nunez et al to Letter Regarding Article, "Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality".
    Circulation. 2018;138:1613-1614.
    PubMed     Text format    


    September 2018
  54. GREENE SJ, Mentz RJ, Fiuzat M, Butler J, et al
    Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.
    Circulation. 2018;138:1039-1053.
    PubMed     Text format     Abstract available


    August 2018
  55. BERTERO E, Canepa M, Maack C, Ameri P, et al
    Linking Heart Failure to Cancer.
    Circulation. 2018;138:735-742.
    PubMed     Text format     Abstract available


  56. ALOIA E
    Letter by Aloia Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Su
    Circulation. 2018;138:656-657.
    PubMed     Text format    


  57. SOLIMAN O, Akin S, Muslem R, Caliskan K, et al
    Response by Soliman et al to Letter Regarding Article, "Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients With Mecha
    Circulation. 2018;138:658-659.
    PubMed     Text format    


    July 2018
  58. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    PubMed     Text format     Abstract available


  59. ANAND IS, Gupta P
    Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies.
    Circulation. 2018;138:80-98.
    PubMed     Text format     Abstract available


  60. ROGER VL
    Heart Failure Epidemic: It's Complicated....
    Circulation. 2018;138:25-28.
    PubMed     Text format    


    June 2018
  61. MCALLISTER DA, Read S, Kerssens J, Livingstone S, et al
    Incidence of Hospitalisation for Heart Failure and Case-Fatality Among 3.25 Million People with and without Diabetes.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.034986.
    PubMed     Text format     Abstract available


  62. YOUNG LH, Viscoli CM, Schwartz GG, Inzucchi SE, et al
    Heart Failure After Ischemic Stroke or TIA in Insulin-Resistant Patients Without Diabetes Treated with Pioglitazone.
    Circulation. 2018 Jun 22. pii: CIRCULATIONAHA.118.034763.
    PubMed     Text format     Abstract available



  63. Correction to: Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury.
    Circulation. 2018;137:e853.
    PubMed     Text format    


    May 2018
  64. PACKER M, Kowey PR
    Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure.
    Circulation. 2018 May 30. pii: CIRCULATIONAHA.118.034583.
    PubMed     Text format     Abstract available


  65. MEHRA MR, Salerno C, Cleveland JC, Pinney S, et al
    Health Care Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study: A Randomized Controlled Trial of a Magnetically Levitated Cardiac Pump in Advanced Heart Failure.
    Circulation. 2018 May 27. pii: CIRCULATIONAHA.118.035722.
    PubMed     Text format     Abstract available


  66. FUDIM M, Jones WS, Boortz-Marx RL, Ganesh A, et al
    Splanchnic Nerve Block for Acute Heart Failure.
    Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035260.
    PubMed     Text format     Abstract available


  67. REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
    A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
    PubMed     Text format     Abstract available


  68. WALKER MA, Tian R
    Raising NAD in Heart Failure: Time to Translate?
    Circulation. 2018;137:2274-2277.
    PubMed     Text format    


  69. ELMING MB, Signorovitch J, Kober L, Thune JJ, et al
    Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2190.
    PubMed     Text format    


  70. ADABAG S, Wininger M, Singh SN
    Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2188-2189.
    PubMed     Text format    


  71. JANUZZI JL JR, Richards AM
    Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study.
    Circulation. 2018;137:2101-2103.
    PubMed     Text format    


  72. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Response by Lytvyn et al to Letter Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".
    Circulation. 2018;137:1984-1985.
    PubMed     Text format    


  73. GROCOTT HP
    Letter by Grocott Regarding Article, "Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials".
    Circulation. 2018;137:1983.
    PubMed     Text format    


  74. PACKER M
    Response by Packer to Letter Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchange Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
    Circulation. 2018;137:1981-1982.
    PubMed     Text format    


  75. GAZMURI RJ, Karmazyn M
    Letter by Gazmuri and Karmazyn Regarding Article, "Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure".
    Circulation. 2018;137:1979-1980.
    PubMed     Text format    


    April 2018
  76. CHIANG DY, Alsina KM, Corradini E, Fitzpatrick M, et al
    Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.
    Circulation. 2018 Apr 18. pii: CIRCULATIONAHA.118.034361.
    PubMed     Text format     Abstract available


  77. KAMIMURA D, Cain LR, Mentz RJ, White WB, et al
    Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.
    Circulation. 2018 Apr 16. pii: CIRCULATIONAHA.117.031912.
    PubMed     Text format     Abstract available


  78. VALIENTE-ALANDI I, Potter SJ, Salvador AM, Schafer AE, et al
    Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Circulation. 2018 Apr 13. pii: CIRCULATIONAHA.118.034609.
    PubMed     Text format     Abstract available


  79. KONSTAM MA, Kiernan MS, Bernstein D, Bozkurt B, et al
    Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 12. pii: CIR.0000000000000560.
    PubMed     Text format     Abstract available


  80. PACKER M
    Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity.
    Circulation. 2018;137:1614-1631.
    PubMed     Text format     Abstract available


    March 2018
  81. KUSHNIR A, Santulli G, Reiken SR, Coromilas E, et al
    Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.117.032703.
    PubMed     Text format     Abstract available


  82. SWEITZER NK, Airhart S
    New Therapeutic Target in Heart Failure: Achieving and Maintaining Normokalemia.
    Circulation. 2018;137:1331-1333.
    PubMed     Text format    


  83. ANDERSSON C, Lyass A, Lin H, Kober L, et al
    Association of Genetic Variation in Coronary Artery Disease-Related Loci With the Risk of Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Circulation. 2018;137:1290-1292.
    PubMed     Text format    


  84. AUBDOOL AA, Argunhan F, Thakore P, Brain SD, et al
    Response by Aubdool et al to Letters Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1201-1202.
    PubMed     Text format    


  85. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1200.
    PubMed     Text format    


  86. TSUDA K
    Letter by Tsuda Regarding Article, "A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure".
    Circulation. 2018;137:1198-1199.
    PubMed     Text format    


  87. RADHOLM K, Figtree G, Perkovic V, Solomon SD, et al
    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.118.034222.
    PubMed     Text format     Abstract available


  88. CHANG PP, Wruck LM, Shahar E, Rossi JS, et al
    Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): The Atherosclerosis Risk in Communities (ARIC) Study Community Surveillance.
    Circulation. 2018 Mar 8. pii: CIRCULATIONAHA.117.027551.
    PubMed     Text format     Abstract available


  89. VIJAYAKUMAR S, Vaduganathan M, Butler J
    Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.
    Circulation. 2018;137:1060-1073.
    PubMed     Text format     Abstract available


    February 2018
  90. MORINE KJ, Qiao X, York S, Natov PS, et al
    Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
    Circulation. 2018 Feb 27. pii: CIRCULATIONAHA.117.031635.
    PubMed     Text format     Abstract available


  91. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
    Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of C
    Circulation. 2018;137:989-991.
    PubMed     Text format    


  92. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovas
    Circulation. 2018;137:988.
    PubMed     Text format    


  93. TAEGTMEYER H, Karlstaedt A
    Letter by Taegtmeyer and Karlstaedt Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Card
    Circulation. 2018;137:986-987.
    PubMed     Text format    


  94. KOH KK
    Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in
    Circulation. 2018;137:984-985.
    PubMed     Text format    


  95. TAMPAKI EC, Tampakis A, Pantos C
    Letter by Tampaki et al Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular O
    Circulation. 2018;137:982-983.
    PubMed     Text format    


  96. PINA IL, Zheng Q, She L, Szwed H, et al
    Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure).
    Circulation. 2018;137:771-780.
    PubMed     Text format     Abstract available


  97. WENGER NK
    Sauce for the Goose Versus Sauce for the Gander: Should Men and Women Play the Same Game But With Different Rules?
    Circulation. 2018;137:791-793.
    PubMed     Text format    


  98. ZHOU L, Miao K, Yin B, Li H, et al
    The Cardioprotective Role of Myeloid-derived Suppressor Cells in Heart Failure.
    Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.030811.
    PubMed     Text format     Abstract available


    January 2018
  99. FLORIDO R, Kwak L, Lazo M, Nambi V, et al
    Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study.
    Circulation. 2018 Jan 31. pii: CIRCULATIONAHA.117.030226.
    PubMed     Text format     Abstract available


  100. REDDY YNV, Obokata M, Gersh BJ, Borlaug BA, et al
    High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.
    Circulation. 2018;137:534-535.
    PubMed     Text format    


  101. KUMBHANI DJ, Fonarow GC, Heidenreich PA, Schulte PJ, et al
    Association Between Hospital Volume, Processes of Care, and Outcomes in Patients Admitted With Heart Failure: Insights From Get With The Guidelines-Heart Failure.
    Circulation. 2018 Jan 29. pii: CIRCULATIONAHA.117.028077.
    PubMed     Text format     Abstract available


  102. OBOKATA M, Borlaug BA
    Response by Obokata and Borlaug to Letters Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:416-417.
    PubMed     Text format    


  103. CARBONE S, Canada JM, Abbate A
    Letter by Carbone et al Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:414-415.
    PubMed     Text format    


  104. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:413.
    PubMed     Text format    


  105. KOUTSAMPASOPOULOS K, Ouzouni C, Vogiatzis I
    Letter by Koutsampasopoulos et al Regarding Article, "Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2018;137:411-412.
    PubMed     Text format    


  106. PANDEY A, Omar W, Ayers C, LaMonte M, et al
    Sex and Race Differences in Lifetime Risk of Heart Failure with Preserved Ejection Fraction and Heart Failure with Reduced Ejection Fraction.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.031622.
    PubMed     Text format     Abstract available


  107. AHMAD T, Jackson K, Rao VS, Tang WHW, et al
    Worsening Renal Function in Acute Heart Failure Patients Undergoing Aggressive Diuresis is Not Associated with Tubular Injury.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.030112.
    PubMed     Text format     Abstract available


  108. AIMO A, Januzzi JL Jr, Vergaro G, Ripoli A, et al
    Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
    Circulation. 2018;137:286-297.
    PubMed     Text format     Abstract available


  109. BORLAUG BA
    Can Oxygen Transport Analysis Tell Us Why People With Heart Failure With Preserved Ejection Fraction Feel So Poorly?
    Circulation. 2018;137:162-165.
    PubMed     Text format    


  110. JOLLY SS, Gao P, Cairns JA, Yusuf S, et al
    Risks of Overinterpreting Interim Data: Lessons From the TOTAL Trial (Thrombectomy With PCI Versus PCI Alone in Patients With STEMI).
    Circulation. 2018;137:206-209.
    PubMed     Text format    


  111. NAMBI V, Deswal A, Ballantyne CM
    Prevention of "Failure": Is It a Failure of Prevention?
    Circulation. 2018;137:106-108.
    PubMed     Text format    


  112. HOUSTIS NE, Eisman AS, Pappagianopoulos PP, Wooster L, et al
    Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O2 Pathway Analysis.
    Circulation. 2018;137:148-161.
    PubMed     Text format     Abstract available


  113. HOWDEN EJ, Sarma S, Lawley JS, Opondo M, et al
    Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial: Implications For Heart Failure Prevention.
    Circulation. 2018 Jan 8. pii: CIRCULATIONAHA.117.030617.
    PubMed     Text format     Abstract available


  114. GERSTEIN HC, Jung H, Ryden L, Diaz R, et al
    Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).
    Circulation. 2018;137:88-90.
    PubMed     Text format    


  115. STEHLIK J, Kobashigawa J, Hunt SA, Reichenspurner H, et al
    Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-of-the-Art Review.
    Circulation. 2018;137:71-87.
    PubMed     Text format     Abstract available


  116. CHUGH SS
    Disrupting the Approach to Sudden Cardiac Death: From Vulnerable Ejection Fraction to Vulnerable Patient.
    Circulation. 2018;137:7-9.
    PubMed     Text format    


    December 2017
  117. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    PubMed     Text format     Abstract available


  118. STIENEN S, Salah K, Moons AH, Bakx AL, et al
    NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial.
    Circulation. 2017 Dec 14. pii: CIRCULATIONAHA.117.029882.
    PubMed     Text format     Abstract available


  119. WU S, Lu Q, Wang Q, Ding Y, et al
    Binding of FUN14 Domain Containing 1 With Inositol 1,4,5-Trisphosphate Receptor in Mitochondria-Associated Endoplasmic Reticulum Membranes Maintains Mitochondrial Dynamics and Function in Hearts in Vivo.
    Circulation. 2017;136:2248-2266.
    PubMed     Text format     Abstract available


    November 2017
  120. DU J, Ma XL, Li Y, Chen B, et al
    Response by Du et al to Letter Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".
    Circulation. 2017;136:2094-2095.
    PubMed     Text format    


  121. LI Y, Liu B, Liang C
    Letter by Li et al Regarding Article, "Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling".
    Circulation. 2017;136:2092-2093.
    PubMed     Text format    


  122. FELDMAN T, Mauri L, Kahwash R, Litwin S, et al
    A Transcatheter InterAtrial Shunt Device for the Treatment of Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): A Phase 2, Randomized, Sham-Controlled Trial.
    Circulation. 2017 Nov 15. pii: CIRCULATIONAHA.117.032094.
    PubMed     Text format     Abstract available



  123. Correction to: Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e345.
    PubMed     Text format    


  124. MEHRA MR, Sundareswaran KS, Uriel N
    Response by Mehra et al to Letter Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
    Circulation. 2017;136:1872-1873.
    PubMed     Text format    


  125. MALTAIS S, Tchantchaleishvili V, Stulak JM
    Letter by Maltais et al Regarding Article, "Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure".
    Circulation. 2017;136:1870-1871.
    PubMed     Text format    


  126. AL-KHATIB SM, Pokorney SD
    Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
    Circulation. 2017;136:1781-1783.
    PubMed     Text format    


    October 2017
  127. LYTVYN Y, Bjornstad P, Udell JA, Lovshin JA, et al
    Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Circulation. 2017;136:1643-1658.
    PubMed     Text format     Abstract available


  128. MANN DL
    High-Resolution Chromatin Mapping in Heart Failure: Some Answers, but More Questions.
    Circulation. 2017;136:1626-1628.
    PubMed     Text format    


  129. WOLSK E, Claggett B, Diaz R, Dickstein K, et al
    Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Circulation. 2017;136:1560-1562.
    PubMed     Text format    


  130. PACKER M
    Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure.
    Circulation. 2017;136:1548-1559.
    PubMed     Text format     Abstract available


  131. RAU CD, Vondriska TM
    DNA Methylation and Human Heart Failure: Mechanisms or Prognostics.
    Circulation. 2017;136:1545-1547.
    PubMed     Text format    


  132. BUTLER J, Anker SD
    The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
    Circulation. 2017;136:1459-1461.
    PubMed     Text format    


  133. NUNEZ J, Bayes-Genis A, Zannad F, Rossignol P, et al
    Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Circulation. 2017 Oct 12. pii: CIRCULATIONAHA.117.030576.
    PubMed     Text format     Abstract available


  134. KATZ SD
    "Pumping Iron" to Improve Exercise Performance in Heart Failure: New Data and New Guidelines.
    Circulation. 2017;136:1384-1386.
    PubMed     Text format    


  135. CHO JH, Zhang R, Kilfoil PJ, Gallet R, et al
    Delayed Repolarization Underlies Ventricular Arrhythmias in Rats with Heart Failure and Preserved Ejection Fraction.
    Circulation. 2017 Oct 3. pii: CIRCULATIONAHA.117.028202.
    PubMed     Text format     Abstract available


    September 2017
  136. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    PubMed     Text format     Abstract available


  137. PANDEY A, Berry JD
    Physical Activity in Heart Failure With Preserved Ejection Fraction: Moving Toward a Newer Treatment Paradigm.
    Circulation. 2017;136:993-995.
    PubMed     Text format    


  138. ELMING MB, Nielsen JC, Haarbo J, Videbaek L, et al
    Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.028829.
    PubMed     Text format     Abstract available


  139. WAAGSTEIN F, Rutherford JD
    The Evolution of the Use of beta-Blockers to Treat Heart Failure: A Conversation With Finn Waagstein, MD.
    Circulation. 2017;136:889-893.
    PubMed     Text format     Abstract available


    August 2017
  140. CHRISTIANSEN MN, Kober L, Andersson C
    Response by Christiansen et al to Letters Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
    Circulation. 2017;136:886-887.
    PubMed     Text format    


  141. KAUL P, Ezekowitz JA, McAlister FA
    Letter by Kaul et al Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
    Circulation. 2017;136:884-885.
    PubMed     Text format    


  142. GABET A, Juilliere Y, Olie V
    Letter by Gabet et al Regarding Article, "Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012".
    Circulation. 2017;136:883.
    PubMed     Text format    


  143. SOLIMAN OI, Akin S, Muslem R, Boersma E, et al
    Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices:The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk
    Circulation. 2017 Aug 27. pii: CIRCULATIONAHA.117.030543.
    PubMed     Text format     Abstract available


  144. MEDER B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, et al
    Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and A Novel Class of Biomarkers for Heart Failure.
    Circulation. 2017 Aug 24. pii: CIRCULATIONAHA.117.027355.
    PubMed     Text format     Abstract available


  145. CHANG LL, DeVore AD, Granger BB, Eapen ZJ, et al
    Leveraging Behavioral Economics to Improve Heart Failure Care and Outcomes.
    Circulation. 2017;136:765-772.
    PubMed     Text format     Abstract available


  146. ROSA-GARRIDO M, Chapski DJ, Schmitt AD, Kimball TH, et al
    High Resolution Mapping of Chromatin Conformation in Cardiac Myocytes Reveals Structural Remodeling of the Epigenome in Heart Failure.
    Circulation. 2017 Aug 11. pii: CIRCULATIONAHA.117.029430.
    PubMed     Text format     Abstract available


  147. ELLINGSEN O, Halle M, Prescott E, Linke A, et al
    Response by Ellingsen et al to Letters Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:611-612.
    PubMed     Text format    


  148. BIANCHI VE
    Letter by Bianchi Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:609-610.
    PubMed     Text format    


  149. WISLOFF U, Lavie CJ, Rognmo O
    Letter by Wisloff et al Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:607-608.
    PubMed     Text format    


  150. IELLAMO F, Volterrani M
    Letter by Iellamo and Volterrani Regarding Article, "High-Intensity Interval Training in Patients With Heart Failure With Reduced Ejection Fraction".
    Circulation. 2017;136:605-606.
    PubMed     Text format    


  151. KUEHN BM
    How Low Is Too Low With Salt in Heart Failure? Randomized Studies Needed to Resolve Concern.
    Circulation. 2017;136:597-598.
    PubMed     Text format    


  152. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    PubMed     Text format     Abstract available


    July 2017
  153. OBOKATA M, Borlaug BA
    Response by Obokata and Borlaug to Letter Regarding Article, "Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study".
    Circulation. 2017;136:430-431.
    PubMed     Text format    


  154. SMISETH OA, Nagueh SF
    Letter by Smiseth and Nagueh et al Regarding Article, "Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study".
    Circulation. 2017;136:428-429.
    PubMed     Text format    


  155. MCALISTER FA, Youngson E, Kaul P
    Health Resource Implications of Heart Failure Hospitalizations in Younger Patients Compared With Older Patients.
    Circulation. 2017;136:424-427.
    PubMed     Text format    


  156. KAPUR NK, Esposito ML, Bader Y, Morine KJ, et al
    Mechanical Circulatory Support Devices for Acute Right Ventricular Failure.
    Circulation. 2017;136:314-326.
    PubMed     Text format     Abstract available


  157. VAN VELDHUISEN DJ, Ponikowski P, van der Meer P, Metra M, et al
    Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency.
    Circulation. 2017 Jul 12. pii: CIRCULATIONAHA.117.027497.
    PubMed     Text format     Abstract available


  158. GILSTRAP LG, DeFilippis EM, Stevenson LW
    An Unintended Consequence of the 21st-Century Cures Act for Patients With Heart Failure.
    Circulation. 2017;136:123-125.
    PubMed     Text format    


  159. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Validity of Cardiovascular Data From Electronic Sources:The Multi-Ethnic Study of Atherosclerosis and HealthLNK.
    Circulation. 2017 Jul 7. pii: CIRCULATIONAHA.117.027436.
    PubMed     Text format     Abstract available


  160. KITZMAN DW, Lam CSP
    Obese Heart Failure With Preserved Ejection Fraction Phenotype: From Pariah to Central Player.
    Circulation. 2017;136:20-23.
    PubMed     Text format    


    June 2017
  161. HEGDE S, Claggett B, Shah AM, Lewis EF, et al
    Physical Activity and Prognosis in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
    Circulation. 2017 Jun 21. pii: CIRCULATIONAHA.117.028002.
    PubMed     Text format     Abstract available


  162. RUBIN GA, Grinspan LT, Ginns J
    Of a Tortuous Nature: An Unusual Cause of Peripartum Congestive Heart Failure.
    Circulation. 2017;135:2567-2571.
    PubMed     Text format    


  163. TAJEU GS, Booth JN 3rd, Colantonio LD, Gottesman RF, et al
    Incident Cardiovascular Disease Among Adults with Blood Pressure < 140/90 mm Hg.
    Circulation. 2017 Jun 20. pii: CIRCULATIONAHA.117.027362.
    PubMed     Text format     Abstract available


    May 2017
  164. PARIKH KS, Lippmann SJ, Greiner M, Heidenreich PA, et al
    Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).
    Circulation. 2017;135:2077-2080.
    PubMed     Text format    


  165. DAVIS J
    Putting the Brakes on Hypertensive Remodeling: An ATF3 Mechanism of Myofibroblast Restraint.
    Circulation. 2017;135:2058-2061.
    PubMed     Text format    


  166. KOSIBOROD M, Cavender MA, Fu AZ, Wilding JP, et al
    Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study.
    Circulation. 2017 May 18. pii: CIRCULATIONAHA.117.029190.
    PubMed     Text format     Abstract available


    April 2017
  167. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of
    Circulation. 2017 Apr 28. pii: CIR.0000000000000509.
    PubMed     Text format    


  168. AUBDOOL AA, Thakore P, Argunhan F, Smillie SJ, et al
    A Novel alpha-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy and Heart Failure.
    Circulation. 2017 Apr 26. pii: CIRCULATIONAHA.117.028388.
    PubMed     Text format     Abstract available


  169. CHOW SL, Maisel AS, Anand I, Bozkurt B, et al
    Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2017 Apr 26. pii: CIR.0000000000000490.
    PubMed     Text format     Abstract available


  170. BRESS AP, Kramer H, Khatib R, Beddhu S, et al
    Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examina
    Circulation. 2017;135:1617-1628.
    PubMed     Text format     Abstract available


  171. VERMA A, Kalman JM, Callans DJ
    Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Circulation. 2017;135:1547-1563.
    PubMed     Text format     Abstract available


  172. GORTER TM, Rienstra M, van Veldhuisen DJ
    Measuring Pulmonary Artery Pressures in Heart Failure: A New Useful Diagnostic Tool?
    Circulation. 2017;135:1518-1521.
    PubMed     Text format    


  173. GORI M, Senni M, Metra M
    High-Sensitive Cardiac Troponin for Prediction of Clinical Heart Failure: Are We Ready for Prime Time?
    Circulation. 2017;135:1506-1508.
    PubMed     Text format    


  174. PACKER M
    Response by Packer to Letter Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
    Circulation. 2017;135:e892-e893.
    PubMed     Text format    


  175. BROWN PM, Ezekowitz JA
    Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective".
    Circulation. 2017;135:e889-e891.
    PubMed     Text format    


  176. URIEL N, Colombo PC, Cleveland JC, Long JW, et al
    Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
    Circulation. 2017 Apr 6. pii: CIRCULATIONAHA.117.028303.
    PubMed     Text format     Abstract available


  177. OBOKATA M, Reddy YN, Pislaru SV, Melenovsky V, et al
    Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2017 Apr 5. pii: CIRCULATIONAHA.116.026807.
    PubMed     Text format     Abstract available


  178. LAM CS, Solomon SD
    Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction.
    Circulation. 2017;135:1279-1280.
    PubMed     Text format    


    March 2017
  179. ROSAMOND WD, Johnson A
    Trends in Heart Failure Incidence in the Community: A Gathering Storm.
    Circulation. 2017;135:1224-1226.
    PubMed     Text format    


  180. METHAWASIN M, Granzier H
    Response by Methawasin and Granzier to Letter Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection F
    Circulation. 2017;135:e681-e682.
    PubMed     Text format    


  181. LEWIS GA, Miller CA
    Letter by Lewis and Miller Regarding Article, "Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function in a Mouse Model of Heart Failure With Preserved Ejection Fraction".
    Circulation. 2017;135:e679-e680.
    PubMed     Text format    


  182. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available


  183. FIDLER MM, Reulen RC, Henson K, Kelly J, et al
    Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.
    Circulation. 2017;135:951-963.
    PubMed     Text format     Abstract available


  184. SUNDSTROM J, Bruze G, Ottosson J, Marcus C, et al
    Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.
    Circulation. 2017 Mar 3. pii: CIRCULATIONAHA.116.025629.
    PubMed     Text format     Abstract available


  185. LI Y, Li Z, Zhang C, Li P, et al
    Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Circulation. 2017 Mar 1. pii: CIRCULATIONAHA.116.024599.
    PubMed     Text format     Abstract available


    February 2017
  186. KONSTAM MA, Abboud FM
    Ejection Fraction: Misunderstood and Overrated (Changing the Paradigm in Categorizing Heart Failure).
    Circulation. 2017;135:717-719.
    PubMed     Text format    


  187. CHRISTIANSEN MN, Kober L, Weeke P, Vasan RS, et al
    Age-specific Trends in Incidence, Mortality and Comorbidities of Heart Failure in Denmark 1995-2012.
    Circulation. 2017 Feb 7. pii: CIRCULATIONAHA.116.025941.
    PubMed     Text format     Abstract available


  188. TIBURCY M, Hudson JE, Balfanz P, Schlick SF, et al
    Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair.
    Circulation. 2017 Feb 6. pii: CIRCULATIONAHA.116.024145.
    PubMed     Text format     Abstract available


  189. SELIGER SL, Hong SN, Christenson RH, Kronmal R, et al
    High Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.116.025505.
    PubMed     Text format     Abstract available


  190. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    PubMed     Text format     Abstract available


    January 2017
  191. SAIKI H, Petersen IA, Scott CG, Bailey KR, et al
    Risk of Heart Failure with Preserved Ejection Fraction in Older Women After Contemporary Radiotherapy for Breast Cancer.
    Circulation. 2017 Jan 29. pii: CIRCULATIONAHA.116.025434.
    PubMed     Text format     Abstract available


  192. PENG D, Zhang Y, Rosenthal DN, Palmon M, et al
    Impact of Heart Transplantation on the Functional Status of U.S. Children with End-Stage Heart Failure. Analysis of Data from the Organ Procurement and Transplantation Network.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.115.016520.
    PubMed     Text format     Abstract available


  193. ATZLER D, McAndrew DJ, Cordts K, Schneider JE, et al
    Dietary Supplementation with Homoarginine Preserves Cardiac Function in a Murine Model of Post-Myocardial Infarction Heart Failure.
    Circulation. 2017;135:400-402.
    PubMed     Text format    


  194. NARAYAN HK, Finkelman BS, French B, Plappert T, et al
    Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations with Ejection Fraction Decline, Recovery, and Heart Failure Symptoms over 3 Years of Followup.
    Circulation. 2017 Jan 19. pii: CIRCULATIONAHA.116.023463.
    PubMed     Text format     Abstract available


  195. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failur
    Circulation. 2017;135:e22-e23.
    PubMed     Text format    


  196. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Pr
    Circulation. 2017;135:e20-e21.
    PubMed     Text format    


  197. ELLINGSEN O, Halle M, Conraads VM, Stoylen A, et al
    High Intensity Interval Training in Heart Failure Patients with Reduced Ejection Fraction.
    Circulation. 2017 Jan 12. pii: CIRCULATIONAHA.116.022924.
    PubMed     Text format     Abstract available


  198. SEIDEL T, Navankasattusas S, Ahmad AA, Diakos NA, et al
    Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading.
    Circulation. 2017 Jan 10. pii: CIRCULATIONAHA.116.024470.
    PubMed     Text format     Abstract available


  199. KRISTENSEN SL, Mogensen UM, Jhund PS, Petrie MC, et al
    Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients with Heart Failure and Preserved Ejection Fraction. A Report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Tria
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.024593.
    PubMed     Text format     Abstract available


    December 2016
  200. OBOKATA M, Kane GC, Reddy YN, Olson TP, et al
    The Role of Diastolic Stress Testing in the Evaluation for HFpEF:A Simultaneous Invasive-Echocardiographic Study.
    Circulation. 2016 Dec 30. pii: CIRCULATIONAHA.116.024822.
    PubMed     Text format     Abstract available


  201. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    PubMed     Text format     Abstract available


  202. MARQUES FZ, Nelson EM, Chu PY, Horlock D, et al
    High Fibre Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in DOCA-Salt Hypertensive Mice.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.024545.
    PubMed     Text format     Abstract available


  203. ABU-TAHA IH, Heijman J, Hippe HJ, Wolf NM, et al
    Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure.
    Circulation. 2016 Dec 7. pii: CIRCULATIONAHA.116.022852.
    PubMed     Text format     Abstract available


    November 2016
  204. NADRUZ W JR, Claggett BL, McMurray JJ, Packer M, et al
    Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Pros
    Circulation. 2016;134:1785-1787.
    PubMed     Text format    


  205. SHAH AM, Claggett B, Loehr LR, Chang PP, et al
    Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.023361.
    PubMed     Text format     Abstract available


  206. MCEVOY JW, Martin SS, Dardari ZA, Miedema MD, et al
    Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    Circulation. 2016 Nov 23. pii: CIRCULATIONAHA.116.025471.
    PubMed     Text format     Abstract available


  207. PACKER M
    Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective.
    Circulation. 2016;134:1664-1678.
    PubMed     Text format     Abstract available


  208. GAGGIN HK, Liu Y, Lyass A, van Kimmenade RR, et al
    Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.023052.
    PubMed     Text format     Abstract available


  209. MEHRA MR, Lindenfeld J
    Highlights of the Annual Scientific Meeting of the Heart Failure Society of America 2016.
    Circulation. 2016;134:1505-1506.
    PubMed     Text format    


  210. ZUHLKE L, Karthikeyan G, Engel ME, Rangarajan S, et al
    Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
    Circulation. 2016;134:1456-1466.
    PubMed     Text format     Abstract available


  211. LYNGBAKKEN MN, Skranes JB, de Lemos JA, Nygard S, et al
    Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023726.
    PubMed     Text format     Abstract available


  212. WANG Q, Liu Y, Fu Q, Xu B, et al
    Inhibiting Insulin-Mediated beta2AR Activation Prevents Diabetes-Associated Cardiac Dysfunction.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.022281.
    PubMed     Text format     Abstract available


  213. MCKELLAR SH, Fang JC
    An Age-Old Question: What Is Too Old for Coronary Artery Bypass Grafting in Heart Failure?
    Circulation. 2016;134:1325-1327.
    PubMed     Text format    


  214. AL-KHATIB SM, Friedman P, Ellenbogen KA
    Defibrillators: Selecting the Right Device for the Right Patient.
    Circulation. 2016;134:1390-1404.
    PubMed     Text format     Abstract available


    October 2016
  215. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


  216. FILIPPOV AA, Del Nido PJ, Vasilyev NV
    Management of Systemic Right Ventricular Failure in Patients With Congenitally Corrected Transposition of the Great Arteries.
    Circulation. 2016;134:1293-1302.
    PubMed     Text format     Abstract available


  217. FRIEDMAN DJ, Bao H, Spatz ES, Curtis JP, et al
    Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report from the National Cardiovascular Data Registry.
    Circulation. 2016 Oct 19. pii: CIRCULATIONAHA.116.022913.
    PubMed     Text format     Abstract available


  218. LEWINTER MM, Zile MR
    Could Modification of Titin Contribute to an Answer for Heart Failure With Preserved Ejection Fraction?
    Circulation. 2016;134:1100-1104.
    PubMed     Text format    


  219. METHAWASIN M, Strom JG, Slater RE, Fernandez V, et al
    Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
    Circulation. 2016;134:1085-1099.
    PubMed     Text format     Abstract available



  220. Correction to: Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?
    Circulation. 2016;134:e307.
    PubMed     Text format    


  221. COWIE MR
    Returning to Work: A Forgotten Aspect of Rehabilitation for Heart Failure.
    Circulation. 2016;134:1010-1012.
    PubMed     Text format    


    September 2016

  222. Correction to: 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart As
    Circulation. 2016;134:e298.
    PubMed     Text format    


  223. MELGARI D, Ng GA, Hancox JC
    Letter by Melgari et al Regarding Article, "Ivabradine: Role in the Chronic Heart Failure Armamentarium".
    Circulation. 2016;134:e296-7.
    PubMed     Text format    


  224. CALVERT PA, Northridge DB, Malik IS, Shapiro L, et al
    Percutaneous Device Closure of Paravalvular Leak: Combined Experience From the United Kingdom and Ireland.
    Circulation. 2016;134:934-44.
    PubMed     Text format     Abstract available



  225. Correction to: Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016;134:e261.
    PubMed     Text format    


  226. WIJESURENDRA RS, Liu A, Eichhorn C, Ariga R, et al
    "Lone" Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persist Despite Successful Catheter Ablation.
    Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.022931.
    PubMed     Text format     Abstract available


    August 2016
  227. PACKER M
    Heart Failure's Dark Secret: Does Anyone Really Care About Optimal Medical Therapy?
    Circulation. 2016;134:629-31.
    PubMed     Text format    


    July 2016
  228. TAEGTMEYER H
    Failing Heart and Starving Brain: Ketone Bodies to the Rescue.
    Circulation. 2016;134:265-6.
    PubMed     Text format    


  229. RAJAPAKSE NW, Kuruppu S, Ian Smith A
    Letter by Rajapakse et al Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Circulation. 2016;134:e9-e10.
    PubMed     Text format    


  230. HUBERS SA, Brown NJ
    Response by Hubers and Brown to Letter Regarding Article, "Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition".
    Circulation. 2016;134:e11-2.
    PubMed     Text format    


  231. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


    May 2016
  232. MCMURRAY JJ
    Disease Management Programs in Cardiology: Extending the Success in Failure.
    Circulation. 2016;133:1836-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: